期刊文献+

超声造影和增强CT诊断小肝癌的差异性和一致性的对比分析 被引量:21

原文传递
导出
摘要 患者女,65岁.发现盆腔包块1月,伴腹胀.绝经5年.查体:盆腔可触及一巨大包块,上界达脐上一横指,界清,质中,活动度可,无压痛.超声检查:盆腔内偏右侧见一椭圆形混合回声肿块,大小约16.5 cm×10.1 cm(图1),包膜清晰完整;实性部分呈低回声,内密布斑点状高回声,约11.5 cm×8.8 cm;囊性部分呈多房性,透声佳,分隔厚薄不均,可见点状强回声及小乳头样突起.彩色多普勒示肿块实性区可见点状血流信号(图2).超声诊断:盆腔内偏右侧囊实混合性包块.CT示右附件区囊实性占位,考虑囊腺癌可能.术中见肿物位于右卵巢,呈囊实性,表面光滑.
出处 《中华超声影像学杂志》 CSCD 北大核心 2014年第5期452-453,共2页 Chinese Journal of Ultrasonography
基金 上海市卫生局重点项目(20114003) 国家自然科学基金(81371570)
  • 相关文献

参考文献7

  • 1Bruix J,Sherman M.Management of hepatocellular carcinoma[J]. Hepatology, 2005,42 : 1208-1236.
  • 2丁红,王文平,张晖,齐青,毛枫,徐智章.肝肿瘤动态灰阶超声造影和增强CT表现的比较研究[J].中华超声影像学杂志,2003,12(12):730-732. 被引量:17
  • 3王俊玲,郑慕白,李志平,李秀英,李树强,潘泉,曹爱梅,仄亮,叶红英,李霞.肝局灶性病变超声造影增强模式与增强CT的对比研究[J].中华超声影像学杂志,2010,19(7):635-636. 被引量:5
  • 4El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular careinoma[J].Gastroenterology, 2008, 134:1752-1763.
  • 5Leoni S,Piscaglia F, Golfieri R, et al.The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria [J].Am J Gastroenterol,2010,105 : 599-609.
  • 6Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatoeellular eareinoma[J]. Hepatology, 2008,47 : 97 -104.
  • 7Bruix J,Sherman M;American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma : an update[J]. Hepatology,2011,53 : 1020-1022.

二级参考文献7

共引文献20

同被引文献185

  • 1刘晓玲,刘健.超声造影在肝硬化增生结节及小肝癌鉴别诊断中的研究进展[J].中华医学超声杂志(电子版),2011,8(10):2215-2219. 被引量:10
  • 2Zenichi Morise,Norihiko Kawabe,Jin Kawase,Hirokazu Tomishige,Hidetoshi Nagata,Hisanori Ohshima,Satoshi Arakawa,Rie Yoshida,Masashi Isetani.Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease[J].World Journal of Hepatology,2013,5(9):487-495. 被引量:21
  • 3欧阳墉,王颖,欧阳雪晖,于明.肝海绵状血管瘤血供和介入治疗的争议和探讨[J].中华放射学杂志,2004,38(7):746-750. 被引量:44
  • 4陈敏华,严昆,杨薇,高文,戴莹,霍苓,张晖,黄信孚.肝细胞癌256例射频消融治疗5年疗效报告[J].北京大学学报(医学版),2005,37(6):671-672. 被引量:14
  • 5Bruix J, Sherman M.Management of hepatocellular carcinoma[J]. Hepatology, 2005, 42 (6) : 1208-1236.
  • 6E1-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatmentofhepatocellularcarcinoma[J].Gastroenterology, 2008, 134 (6) : 1752-1763.
  • 7Leoni S, Piscaglia F, Golfieri R, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria[J]. Am J Gastroenterol, 2010, 105 (3) : 599-609.
  • 8Bmix J, Sherman M.American Association for the Study of Liver Diseases.Management of hepatocel|ular carcinoma: an update[J]. Hepatology, 2011, 53 (21) : 1020-1022.
  • 9FurIan, A.,Marin, D.,Cabassa, P. et al. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: Intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for 'the Study of Liver Diseases (AASLD) guidelines[J].European Journal of Radiology, 2012, 81 (9) : 2099- 2105.
  • 10Yanzhao Zhao et al. Design assessment of Qi Yao, Hut tan and preliminary - (99m) Tc-1 abe 1 ed ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/ magnetic resonance imaging of hepatocellular carcinoma[J]. Journal of Radioanalytical and Nuclear Chemistry: An International Journal Dealing with All Aspects and Applications of Nuclear Chemistry, 2014,299(3):1273- 1280.

引证文献21

二级引证文献201

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部